Arcutis Biotherapeutics (ARQT) Debt/EBITDA US GAAP (year values) |
|||||||||
2020 | 2021 | 2021 | 2022 | 2023 | LTM ? | CAGR 5 years ? | |||
Debt/EBITDA | 2.07 | 1.50 | 1.51 | 0.70 | 0.29 | 0.90 | |||
Changes by years, y/y, % | -14% | -27% | +0% | -53% | -59% | -35.4% |
Arcutis Biotherapeutics. Debt/EBITDA
Arcutis Biotherapeutics. Debt/EBITDA, changes, %
Arcutis Biotherapeutics (ARQT) Debt/EBITDA US GAAP (quarter values) |
||||||||
2023Q4 | 2024Q1 | 2024Q1 | 2024Q2 | 2024Q3 | LTM ? | |||
Debt/EBITDA | 0.29 | 1.04 | 1.21 | 0.95 | 0.75 | 0.90 | ||
Changes by years, y/y, % | -58% | +147% | +187% | +349% | +701% | |||
Changes by quarters, q/q, % | +213% | +256% | +16% | -21% | -21% |